OPEN END TURBO LONG - QUEST DIAGNOSTICS | Real-time Bid/Ask 09:36:18 24/05/2024 pm IST | ||
| 2.62 EUR / 2.64 EUR | -0.75% |
|
| Current month | +2.71% | ||
| 1 month | +11.34% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 2.61 | -1.51% |
| 23/24/23 | 2.65 | -3.99% |
| 22/24/22 | 2.76 | -4.83% |
| 21/24/21 | 2.9 | -2.36% |
| 20/24/20 | 2.97 | +2.77% |
Delayed Quote Börse Stuttgart
Last update May 24, 2024 at 07:27 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | ME92D5 |
| ISIN | DE000ME92D55 |
| Date issued | 21/02/2024 |
| Strike | 112.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.37 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.07 € |
|---|---|
| Lowest since issue | 1.17 € |
| Spread | 0.03 € |
| Spread % | 1.14% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
140
USD
Average target price
146.8
USD
Spread / Average Target
+4.83%
- Stock Market
- Certificates
- Certificat
